Community-acquired pneumonia

Update on antibiotic therapy

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

For patients with mild to moderately severe community-acquired pneumonia, a routine clinical assessment and a chest film are indicated, but Gram's staining and culturing of sputum are of limited value. We use an empiric approach to therapy that is hosed on age, co-morbid conditions, severity of illness, and whether hospitalization is required. For patients younger than 60 years who do not need to be admitted, macrolides are the treatment of choice. For those age 60 or older, as well as younger patients with co-morbid conditions, we recommend a second-generation cephalosparin or a β-lactam/β-lactamase inhibitor combination. For those who require hospitalization, consider a second- or third-generation cephalosporin or a β-lactam/β-lactamase inhibitor combination. Finally, for seriously ill patients in the ICU, we recommend an intravenous macrolide plus a third- generation cephalosparin with antipseudomonal activity or another antipseudomonal agent, such as ciprofloxacin or imipenem/cilastatin. These recommendations are not intended for patients who have HIV infection/AIDS or who are receiving immunosuppressive drugs.

Original languageEnglish (US)
Pages (from-to)1659-1676
Number of pages18
JournalConsultant
Volume38
Issue number7
StatePublished - Jul 1998

Fingerprint

Pneumonia
Anti-Bacterial Agents
Lactams
Macrolides
Hospitalization
Therapeutics
Cephalosporins
Motion Pictures
Immunosuppressive Agents
Ciprofloxacin
Sputum
HIV Infections
Acquired Immunodeficiency Syndrome
Thorax
Staining and Labeling
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Community-acquired pneumonia : Update on antibiotic therapy. / Boyars, Michael; Mercado, Anita.

In: Consultant, Vol. 38, No. 7, 07.1998, p. 1659-1676.

Research output: Contribution to journalArticle

@article{eeac5b38eb054ce98674b4c53d3e254d,
title = "Community-acquired pneumonia: Update on antibiotic therapy",
abstract = "For patients with mild to moderately severe community-acquired pneumonia, a routine clinical assessment and a chest film are indicated, but Gram's staining and culturing of sputum are of limited value. We use an empiric approach to therapy that is hosed on age, co-morbid conditions, severity of illness, and whether hospitalization is required. For patients younger than 60 years who do not need to be admitted, macrolides are the treatment of choice. For those age 60 or older, as well as younger patients with co-morbid conditions, we recommend a second-generation cephalosparin or a β-lactam/β-lactamase inhibitor combination. For those who require hospitalization, consider a second- or third-generation cephalosporin or a β-lactam/β-lactamase inhibitor combination. Finally, for seriously ill patients in the ICU, we recommend an intravenous macrolide plus a third- generation cephalosparin with antipseudomonal activity or another antipseudomonal agent, such as ciprofloxacin or imipenem/cilastatin. These recommendations are not intended for patients who have HIV infection/AIDS or who are receiving immunosuppressive drugs.",
author = "Michael Boyars and Anita Mercado",
year = "1998",
month = "7",
language = "English (US)",
volume = "38",
pages = "1659--1676",
journal = "Consultant",
issn = "0010-7069",
publisher = "Cliggott Publishing Co.",
number = "7",

}

TY - JOUR

T1 - Community-acquired pneumonia

T2 - Update on antibiotic therapy

AU - Boyars, Michael

AU - Mercado, Anita

PY - 1998/7

Y1 - 1998/7

N2 - For patients with mild to moderately severe community-acquired pneumonia, a routine clinical assessment and a chest film are indicated, but Gram's staining and culturing of sputum are of limited value. We use an empiric approach to therapy that is hosed on age, co-morbid conditions, severity of illness, and whether hospitalization is required. For patients younger than 60 years who do not need to be admitted, macrolides are the treatment of choice. For those age 60 or older, as well as younger patients with co-morbid conditions, we recommend a second-generation cephalosparin or a β-lactam/β-lactamase inhibitor combination. For those who require hospitalization, consider a second- or third-generation cephalosporin or a β-lactam/β-lactamase inhibitor combination. Finally, for seriously ill patients in the ICU, we recommend an intravenous macrolide plus a third- generation cephalosparin with antipseudomonal activity or another antipseudomonal agent, such as ciprofloxacin or imipenem/cilastatin. These recommendations are not intended for patients who have HIV infection/AIDS or who are receiving immunosuppressive drugs.

AB - For patients with mild to moderately severe community-acquired pneumonia, a routine clinical assessment and a chest film are indicated, but Gram's staining and culturing of sputum are of limited value. We use an empiric approach to therapy that is hosed on age, co-morbid conditions, severity of illness, and whether hospitalization is required. For patients younger than 60 years who do not need to be admitted, macrolides are the treatment of choice. For those age 60 or older, as well as younger patients with co-morbid conditions, we recommend a second-generation cephalosparin or a β-lactam/β-lactamase inhibitor combination. For those who require hospitalization, consider a second- or third-generation cephalosporin or a β-lactam/β-lactamase inhibitor combination. Finally, for seriously ill patients in the ICU, we recommend an intravenous macrolide plus a third- generation cephalosparin with antipseudomonal activity or another antipseudomonal agent, such as ciprofloxacin or imipenem/cilastatin. These recommendations are not intended for patients who have HIV infection/AIDS or who are receiving immunosuppressive drugs.

UR - http://www.scopus.com/inward/record.url?scp=0032323797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032323797&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 1659

EP - 1676

JO - Consultant

JF - Consultant

SN - 0010-7069

IS - 7

ER -